Seeking Alpha

  Cyclacel Pharmaceuticals, Inc. (CYCC) - NASDAQ

  • The Scientist | Send Message 1 Jun 2012

    CYCC came out with great data on sapacitabine for MDS. Not only does it work well, but it also an ORAL med. Wall St ignoring good data again
    Reply (1)
    • John Rayhall | Send Message 15 Oct 2012
      : Looks like they are listening today. Too late to buy some?
      CYCC vs. ETF Alternatives
      Company Description
      Cyclacel Pharmaceuticals Inc is a development-stage biopharmaceutical company engaged in the development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious diseases.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States